IP Library Granted Patent US 9,624,533
Granted Patent B2
US 9,624,533 · App. 14/099,821 · Granted Apr 18, 2017

Multiplex nucleic acid detection methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,624,533
App. No.
14/099,821
Granted
Apr 18, 2017
Kind
B2
Abstract

Methods for multiplex ligation-dependent probe amplification include (a) providing a sample tissue to query different target nucleic acids, (b) providing different probe sets for each of the target nucleic acids, each probe set including a first locus specific probe having a first adapter sequence and a first target specific portion and a second locus specific probe having a second adapter sequence, and a second target specific portion adjacent to the first target specific portion, (c) hybridizing the probe sets to the target sequences to form hybridization complexes, (d) ligating the hybridization complexes to form ligated probes, (e) amplifying the ligated probes to form amplicons, the amplifying step being carried out with a first universal primer including a region complementary to the first adapter sequence and a second universal primer including a region complementary to the second adapter sequence, and (f) detecting the amplicons in a detection system by sequencing each of the amplicons.

Claims (30)

1. A method for multiplex ligation-dependent probe amplification comprising:

(a) providing a sample tissue to query at least 100 different target nucleic acids;

(b) providing a plurality of different probe sets for each of the at least 100 different target nucleic acids, wherein each probe set comprises:

a first locus specific probe comprising a first adapter sequence and a first target specific portion; and

a second locus specific probe comprising a second adapter sequence, and a second target specific portion adjacent to the first target specific portion;

(c) hybridizing the plurality of different probe sets to the at least 100 different target sequences to form at least 100 different hybridization complexes;

(d) ligating, in a single vessel or tube, the at least 100 different hybridization complexes to form at least 100 different ligated probes;

(e) amplifying the at least 100 different ligated probes to form at least 100 different amplicons, wherein (i) the amplifying step is carried out with a first universal primer comprising a region complementary to the first adapter sequence and a second universal primer comprising a region complementary to the second adapter sequence, and (ii) the amplifying of the at least 100 different ligated probes is carried out in the single vessel or tube; and

(f) detecting the at least 100 different amplicons in a detection system, independently of the length, by sequencing each of the at least 100 different amplicons wherein said at least 100 different ligated probes of step (d) are directly amplified in step (e) without purification.

2. The method of claim 1 , further comprising determining the copy number for each of the at least 100 different target nucleic acids.

3. The method of claim 1 , wherein the at least 100 different target nucleic acids is at least 1000 different target nucleic acids, the at least 100 different hybridization complexes is at least 1000 different hybridization complexes, the at least 100 different ligated probes is at least 1000different ligated probes, and the at least 100 different amplicons is at least 1000 different amplicons.

4. The method of claim 1 , wherein the at least 100 different target nucleic acids is in a range from about 100 to about 500 target nucleic acids, the at least 100 different hybridization complexes is in a range from about 100 to about 500 different hybridization complexes, the at least 100 different ligated probes is in a range from about 100 to about 500 different ligated probes, and the at least 100 different amplicons is in a range from about 100 to about 500 different amplicons.

5. The method of claim 1 , wherein the at least 100 different target nucleic acids is in a range from about 100 to about 1,000 target nucleic acids, the at least 100 different hybridization complexes is in a range from about 100 to about 1,000 different hybridization complexes, the at least 100 different ligated probes is in a range from about 100 to about 1,000 different ligated probes, and the at least 100 different amplicons is in a range from about 100 to about 1,000 different amplicons.

6. The method of claim 1 , wherein the at least 100 different target nucleic acids is in a range from about 100 to about 10 8 target nucleic acids, the at least 100 different hybridization complexes is in a range from about 100 to about 10 8 different hybridization complexes, the at least 100 different ligated probes is in a range from about 100 to about 10 8 different ligated probes, and the at least 100 different amplicons is in a range from about 100 to about 10 8 different amplicons.

7. The method of claim 1 , wherein at least one of the first universal primer and the second universal primer further comprises an indexing sequence.

8. The method of claim 1 , wherein the detection system comprises sequencing by synthesis.

9. The method of claim 8 , wherein the detection system comprises a fluidics handling system configured to perform cycles of sequencing by synthesis on an array comprising the at least 100 different amplicons, the detection system configured to direct radiation from a source to the array and to direct fluorescence emission from the array to a camera, and a system control interface configured to automatically modify the detection system to increase the exposure level of the radiation directed to the array and detect fluorescence emission from the array to the camera at the increased exposure.

10. The method of claim 1 , wherein the method comprises detecting a single nucleotide polymorphism.

11. The method of claim 1 , wherein the method comprises determining a degree of methylation of at least a portion of the at least 100 different target nucleic acids.

12. The method of claim 1 , wherein the method comprises quantifying a target mRNA.

13. The method of claim 1 , wherein the hybridizing of (c), the ligating of (d) and the amplifying of (e) are carried out in the single vessel or tube.

14. A method for multiplex ligation-dependent probe amplification comprising:

(a) contacting at least 100 different target nucleic acids with at least 100 different probe sets for each of the different target nucleic acids, wherein each probe set comprises,

(i) a first locus specific probe comprising a first adapter sequence and a first target specific portion, and

(ii) a second locus specific probe comprising a second adapter sequence, and a second target specific portion adjacent to the first target specific portion,

wherein the probe sets hybridize to the target sequences thereby forming at least 100 different hybridization complexes in a single mixture, wherein the at least 100 different hybridization complexes comprise the at least 100 different target nucleic acids and the at least 100 different probe sets;

(b) ligating the at least 100 different hybridization complexes in the mixture, thereby providing at least 100 different ligated probes comprised in the mixture;

(c) amplifying the at least 100 different ligated probes in the mixture to form at least 100 different amplicons, wherein the amplifying is carried out with a first universal primer comprising a region complementary to the first adapter sequence and a second universal primer comprising a region complementary to the second adapter sequence; and

(d) detecting the at least 100 different amplicons in the mixture in a detection system by sequencing each of the at least 100 different amplicons wherein said at least 100 different ligated probes of step (b) are directly amplified in step (c) without purification.

15. The method of claim 14 , wherein the detection system comprises sequencing by synthesis.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2024
From: INVITAE CORPORATION
To: LABORATORY CORPORATION OF AMERICA HOLDINGS
Reel/Frame 068822/0025 →
SECURITY INTEREST Recorded Mar 13, 2023
From: INVITAE CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 063787/0148 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: INVITAE CORPORATION; GOOD START GENETICS, INC.; SINGULAR BIO, INC.; YOUSCRIPT, LLC
Reel/Frame 063282/0538 →
PATENT SECURITY AGREEMENT Recorded Oct 2, 2020
From: INVITAE CORPORATION; GOOD START GENETICS, INC.; SINGULAR BIO, INC.; YOUSCRIPT, LLC
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 054234/0872 →
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2019
From: INN SA LLC
To: INVITAE CORPORATION; GOOD START GENETICS, INC.; COMBIMATRIX CORPORATION
Reel/Frame 050454/0559 →
SECURITY INTEREST Recorded Nov 6, 2018
From: INVITAE CORPORATION; GOOD START GENETICS, INC.; COMBIMATRIX CORPORATION
To: INN SA LLC
Reel/Frame 047889/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2016
From: OLIVARES, ERIC; SORENSON, JON; LANDERS, TOM
To: INVITAE CORPORATION
Reel/Frame 040468/0504 →